Technical Analysis for HTBX - Heat Biologics, Inc.

Grade Last Price % Change Price Change
grade C 2.17 2.84% 0.06
HTBX closed up 2.84 percent on Friday, August 7, 2020, on 33 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat
Historical HTBX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 20 DMA Bearish 2.84%
Narrow Range Bar Range Contraction 2.84%
NR7 Range Contraction 2.84%
NR7-2 Range Contraction 2.84%
Stochastic Reached Oversold Weakness 2.84%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Heat Biologics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. It is developing Immune Pan Antigen Cytotoxic therapy, a platform technology that delivers human cells that are reprogrammed to pump out various cancer associated antigens together with a potent immune adjuvant. The company's products under development include HS-110 that is in Phase II clinical trials for the treatment of non-small cell lung cancer; HS-410 for the bladder cancer treatment; HS-310 to treat ovarian cancer; and HS-510 for treating triple negative breast cancer. Its products also comprise HS-HIV product candidate for the treatment and prevention of HIV. The company was founded in 2008 and is based in Chapel Hill, North Carolina.
Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Treatment Of Cancer Cancers Non Small Cell Lung Cancer Ovarian Cancer Vaccination Cancer Treatment HIV Vaccine Platform Technology Treatment Of Non Small Cell Lung Cancer Biotechnology Companies Bladder Cancer Cancer Vaccine Triple Negative Breast Cancer Chapel Hill Heat Biologics Neuvenge

Is HTBX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.3
52 Week Low 0.195
Average Volume 34,091,352
200-Day Moving Average 0.72
50-Day Moving Average 1.40
20-Day Moving Average 2.25
10-Day Moving Average 2.18
Average True Range 0.36
ADX 49.23
+DI 32.26
-DI 15.01
Chandelier Exit (Long, 3 ATRs ) 3.22
Chandelier Exit (Short, 3 ATRs ) 1.95
Upper Bollinger Band 3.37
Lower Bollinger Band 1.13
Percent B (%b) 0.46
BandWidth 99.42
MACD Line 0.23
MACD Signal Line 0.31
MACD Histogram -0.0836
Fundamentals Value
Market Cap 77.66 Million
Num Shares 35.8 Million
EPS -0.43
Price-to-Earnings (P/E) Ratio -5.05
Price-to-Sales 26.16
Price-to-Book 2.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.32
Resistance 3 (R3) 2.31 2.26 2.30
Resistance 2 (R2) 2.26 2.22 2.26 2.29
Resistance 1 (R1) 2.21 2.19 2.24 2.22 2.28
Pivot Point 2.16 2.16 2.17 2.16 2.16
Support 1 (S1) 2.11 2.12 2.14 2.12 2.06
Support 2 (S2) 2.06 2.09 2.06 2.05
Support 3 (S3) 2.01 2.06 2.05
Support 4 (S4) 2.02